FR2110233B1 - - Google Patents

Info

Publication number
FR2110233B1
FR2110233B1 FR7135858A FR7135858A FR2110233B1 FR 2110233 B1 FR2110233 B1 FR 2110233B1 FR 7135858 A FR7135858 A FR 7135858A FR 7135858 A FR7135858 A FR 7135858A FR 2110233 B1 FR2110233 B1 FR 2110233B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7135858A
Other languages
French (fr)
Other versions
FR2110233A1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Richardson Vicks Inc
Original Assignee
Richardson Merrell Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richardson Merrell Inc filed Critical Richardson Merrell Inc
Publication of FR2110233A1 publication Critical patent/FR2110233A1/fr
Application granted granted Critical
Publication of FR2110233B1 publication Critical patent/FR2110233B1/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7135858A 1970-10-05 1971-10-05 Expired FR2110233B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7825870A 1970-10-05 1970-10-05

Publications (2)

Publication Number Publication Date
FR2110233A1 FR2110233A1 (en) 1972-06-02
FR2110233B1 true FR2110233B1 (en) 1974-09-06

Family

ID=22142910

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7135858A Expired FR2110233B1 (en) 1970-10-05 1971-10-05

Country Status (8)

Country Link
AU (1) AU462092B2 (en)
BE (1) BE773518A (en)
CA (1) CA963806A (en)
DE (1) DE2149281A1 (en)
FR (1) FR2110233B1 (en)
GB (1) GB1326528A (en)
IL (1) IL37772A (en)
ZA (1) ZA716118B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4370321A (en) * 1976-09-01 1983-01-25 Mead Johnson And Company Progestational adjuvant therapy
US6326392B1 (en) 1997-11-06 2001-12-04 American Home Products Corporation Anti-estrogen plus progestin containing oral contraceptives
UA68365C2 (en) * 1997-11-06 2004-08-16 Wyeth Corp Peroral contraception by combination of anti-estrogen and progestin
CA3112122A1 (en) * 2020-03-20 2021-09-20 Apotex Inc. Salts of zuclomiphene

Also Published As

Publication number Publication date
FR2110233A1 (en) 1972-06-02
ZA716118B (en) 1972-05-31
DE2149281A1 (en) 1972-04-06
IL37772A0 (en) 1971-11-29
BE773518A (en) 1972-01-31
CA963806A (en) 1975-03-04
AU462092B2 (en) 1975-06-12
AU3406071A (en) 1973-04-05
GB1326528A (en) 1973-08-15
IL37772A (en) 1975-04-25

Similar Documents

Publication Publication Date Title
AU465454B2 (en)
FR2110233B1 (en)
AU1473870A (en)
AU2044470A (en)
AU2017870A (en)
AU1833270A (en)
AU1716970A (en)
AU2085370A (en)
AU1517670A (en)
AU2130570A (en)
AU2144270A (en)
AU1974970A (en)
AU1832970A (en)
AU1343870A (en)
AU1841070A (en)
AU1872870A (en)
AU1879170A (en)
AU1881070A (en)
AU1918570A (en)
AU1943370A (en)
AU1969370A (en)
AU1789870A (en)
AU1581370A (en)
AU1689770A (en)
AU2061170A (en)

Legal Events

Date Code Title Description
ST Notification of lapse